Favorable Head-to-Head Data on iMDx’s GraftAssure with Competing NGS Assay Published in Clinical Chemistry

Go back to Favorable Head-to-Head Data on iMDx’s GraftAssure with Competing NGS Assay Published in Clinical Chemistry
(NASDAQ: IMDX) Delayed: 4.21 +0.08 (1.94%)
Previous Close $4.13    52 Week High
Open $4.13    52 Week Low
Day High $4.32    P/E N/A 
Day Low $3.85    EPS
Volume 75,578